Islatravir
Showing 1 - 21 of 21
Human Immunodeficiency Virus (HIV) Infections Trial (Islatravir)
Not yet recruiting
- Human Immunodeficiency Virus (HIV) Infections
- Islatravir
- (no location specified)
Jun 21, 2022
Human Immunodeficiency Virus (HIV) Infection Trial in Miami, Berlin (Islatravir)
Completed
- Human Immunodeficiency Virus (HIV) Infection
- Islatravir
-
Miami, Florida
- +1 more
Sep 29, 2021
Human Immunodeficiency Virus (HIV) Infection Trial in Miami (Islatravir)
Completed
- Human Immunodeficiency Virus (HIV) Infection
- Islatravir
-
Miami, FloridaClinical Pharmacology of Miami ( Site 0001)
Sep 20, 2021
Human Immunodeficiency Virus, HIV Trial (Islatravir, Placebo)
Not yet recruiting
- Human Immunodeficiency Virus
- HIV
- Islatravir
- Placebo
- (no location specified)
Oct 13, 2022
HIV-1 Infection Trial in Israel, South Africa, United States (Islatravir, Placebo)
Active, not recruiting
- HIV-1 Infection
- Islatravir
- Placebo
-
Hollywood, Florida
- +8 more
Aug 24, 2022
HIV-1 Infection Trial in Worldwide (DOR/ISL)
Active, not recruiting
- HIV-1 Infection
-
Washington, District of Columbia
- +16 more
Oct 13, 2022
HIV-I, Human Immunodeficiency Virus Type 1, Prophylaxis Trial in South Africa, Uganda, United States (Islatravir, Placebo to
Active, not recruiting
- HIV-I
- +2 more
- Islatravir
- +3 more
-
Birmingham, Alabama
- +23 more
Aug 15, 2022
HIV Preexposure Prophylaxis Trial in Worldwide (ISL, FTC/TDF, FTC/TAF)
Active, not recruiting
- HIV Preexposure Prophylaxis
- ISL
- +5 more
-
Birmingham, Alabama
- +24 more
Aug 15, 2022
HIV Infection Trial in Worldwide (DOR/ISL, BIC/FTC/TAF, Placebo to BIC/FTC/TAF)
HIV Trial in Paris (Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine)
Not yet recruiting
- HIV Infections
- Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine
-
Paris, Ile De France, FranceChristine Katlama
Jul 26, 2022